explore -WSS

explore

author：leisure time 2025-09-30 23:06:15 - browse：6

Surrounded by tablets, an elder miniature figure walks with a cane next to a stethoscope — coverage from STAT — Adobe

Medicare Advantage is arguably the most controversial health care program right now — a sentiment that was bolstered Friday by striking new data about overpayments and an uncommon political jab during a routine meeting of policy wonks.

The Medicare Payment Advisory Commission, a group that advises Congress on Medicare policy, gathered to discuss its pending March report on the state of Medicare Advantage, the alternative to traditional Medicare that is run by health insurance companies. Medicare Advantage is expected to cost taxpayers $507 billion this year, according to the latest federal estimates.

The group, known as MedPAC, came to several familiar conclusions from the staff’s presentation and report: The federal government significantly overpays Medicare Advantage insurers because they attract healthier, lower-cost people into their plans and then excessively code those people’s health conditions — making Medicare Advantage a drain on taxpayers. MedPAC’s staffers also reiterated that Medicare Advantage’s quality rating system is “not a good basis for judging quality,” and therefore leads to further overpayments because insurers are paid bonuses based on this quality system.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： Companies helping big Covid

WSS

EU fines Illumina $475 million over Grail acquisition

Iran's president begins a rare visit to Africa 'to promote economic diplomacy'

Grail's uphill battle for Medicare to cover its cancer screening test

The debate over Covid

STAT Summit: Michael J. Fox on progress in Parkinson's research

How climate

Wikipedia

explore

focus

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

STAT Summit: GSK CEO on pharma giant's new direction

After affirmative action ruling, medical educators look to 'holistic review'

UnitedHealth’s board chair also owns a personal investment firm

23andMe had bad news about my health. I wish a person had delivered it

EU fines Illumina $475 million over Grail acquisition

Sports medicine is finally prioritizing gender equality

China sends large group of warplanes, navy ships towards Taiwan in forceful display

Apple is now the first public company to be valued at $3 trillion

FDA struggles to regulate food additives, sometimes for decades

focus

UnitedHealth’s board chair also owns a personal investment firm

A Greenpeace activist is fined for crash

Vermont grapples with historic flooding as more rainstorms head for Northeast

Solve the antibiotic resistance crisis with preventive drugs

Why health workers in Gaza are injured or die at high rates

Grail's uphill battle for Medicare to cover its cancer screening test

hotspot

explore

focus

focus